Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2005-003755-12Phase 4Completed
Phase 4, randomised trial of cisplatin and fluorouracil in esophageal cancer (2 arms), sponsored by Hull University Teaching Hospitals. Primary endpoint: Relief of dysphagia (primary). Started Nov 2005; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2005-003755-12.